LGALS9 and neoplasm: Further studies in a mouse model of HNSCC, showed that this lectin generates an immunosuppressive barrier that prevents T cell migration to the tumor, particularly by up-regulation of immune-inhibitory ligands including PD-L1 and Galectin-9 (Gal-9).